The role of the (18)F-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker Screenings Onderzoek lung cancer screening trial

Journal of Thoracic Oncology

Volumn 6, Issue 10, 2011, Pages 1704-1712

  Vant Westeinde, Susan C ^a   De Koning, Harry J ^a   Thunnissen, Frederik B ^b   Oudkerk, Matthijs ^c   Groen, Harry J M ^c   Lammers, Jan Willem J ^d   Weenink, Carla ^e   Vernhout, Rene ^a   Nackaerts, Kristiaan ^f   Mali, Willem ^d   Van Klaveren, Rob J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e RC ^*  (Netherlands)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Benign nodule; Lung cancer; PET scan; Positron emission tomography; Pulmonary nodule; Thoracic surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER SCREENING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSERVATIVE TREATMENT; FOLLOW UP; GOLD STANDARD; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; CANCER STAGING; FEMALE; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MASS SCREENING; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

EID: 80052962094     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182286d0b     Document Type: Article

References (37)

1. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
2. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351:1242-1245. (Pubitemid 28181964)
3. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105. (Pubitemid 29313143)
4. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-597. (Pubitemid 37013298)
5. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-265. (Pubitemid 40432263)
6. NLST. Available at: http://www.cancer.gov/clinicaltrials/NCI-NLS. Accessed October 21, 2009.
7. van Klaveren RJ, Oudkerk M, Prokop, M, et al. A novel management strategy for CT detected lung nodules based on volumetry. New Engl J Med 2009;361:2221-2229.
8. Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 2008;59:355-363. (Pubitemid 351335108)
9. Blanchon T, Brechot JM, Grenier PA, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007;58:50-58. (Pubitemid 47385930)
10. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-184. (Pubitemid 44802721)
11. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-874. (Pubitemid 46175408)
12. Bolte H, Riedel C, Muller-Hulsbeck S, et al. Precision of computeraided volumetry of artificial small solid pulmonary nodules in ex vivo porcine lungs. Br J Radiol 2007;80:414-421. (Pubitemid 47322228)
13. Wormanns D, Kohl G, Klotz E, et al. Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility. Eur Radiol 2004;14:86-92. (Pubitemid 38181058)
14. Longcarcinoom: CRN-K. Stadiering en behandeling. Van Zuiden Communications BV, Alphen aan de Rijn, The Netherlands, 2004.
15. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717. (Pubitemid 27260107)
16. Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361:32-39.
17. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002;359:1388-1393.
18. Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007;34:392-404. (Pubitemid 46295349)
19. Veronesi G, Bellomi M, Veronesi U, et al. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg 2007;84: 959-965.
20. Bastarrika G, Garcia-Velloso MJ, Lozano MD, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005;171:1378-1383. (Pubitemid 40800510)
21. Lindell RM, Hartman TE, Swensen SJ, et al. Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population. AJR Am J Roentgenol 2005;185:126-131.
22. Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132(Suppl 3):94S-107S. (Pubitemid 47502802)
23. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914-924. (Pubitemid 32171553)
24. Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-121. (Pubitemid 38943126)
25. Veronesi G, Bellomi M, Scanagatta P, et al. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg 2008;136:611-617.
26. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first CT Scan. Am J Respir Crit Care Med 2008;178:956-961.
27. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial- overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-614.
28. Lopes Pegna A, Picozzi G, Mascalchi M, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
29. Menezes RJ, Roberts HC, Paul NS, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 2009;67:177-183.
30. McWilliams A, Mayo J, MacDonald S, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003;168:1167-1173. (Pubitemid 37421833)
31. Nomori H, Watanabe K, Ohtsuka T, et al. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg 2005;79:984-988. (Pubitemid 40288761)
32. O JH, Yoo Ie R, Kim SH, et al. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. J Nucl Med 2007;48:15-21.
33. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006;82:1016-1020.
34. Hashimoto Y, Tsujikawa T, Kondo C, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 2006;47:426-431. (Pubitemid 46768484)
35. Christensen JA, Nathan MA, Mullan BP, et al. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol 2006;187:1361-1367. (Pubitemid 44630846)
36. Dooms C, Vansteenkiste J. Positron emission tomography in nonsmall cell lung cancer. Curr Opin Pulm Med 2007;13:256-260. (Pubitemid 46847288)
37. Herder GJ, Golding RP, Hoekstra OS, et al. The performance of (18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2004;31:1231-1236. (Pubitemid 39222486)